TEX44

Across TCGA pan-cancer cohorts, TEX44 Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated TEX44 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TEX44 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TEX44 expression acts as an unfavorable survival marker.

LUAD, OV, and SKCM are the cancer types where TEX44 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.230	0.686	<.001	21	view →
OV	OS	Median	All	0.362	0.842	.005	18	view →
SKCM	OS	Median	All	0.216	0.781	.001	15	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
ESCA	OS	Median	II,III,IV	0.277	0.686	.026	6	view →
STAD	OS	Median	II,III,IV	0.170	0.558	.035	3	view →
LUSC	OS	Median	All	0.345	0.678	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

TEX44–LUAD (OS)

Open the LUAD breakdown →